The appointments reflect Wolters Kluwer’s continued focus on advancing healthcare technology and growing expert solutions across the continuum of healthcare
Wolters Kluwer Health announces the appointments of Gregory Samios as President & CEO of Clinical Effectiveness and Dr Peter Bonis as Chief Medical Officer (CMO) of the division, effective December 1, 2021. The appointments reflect Wolters Kluwer’s continued focus on advancing healthcare technology and growing expert solutions across the continuum of healthcare.
Samios succeeds Dr Denise Basow, who moved out after 25 years of service. Samios brings decades of experience as a customer-focused executive in the healthcare and legal information sectors. Most recently, he served as President and CEO of Health Learning, Research & Practice (HLRP). Throughout his career, Samios has been passionate about working together with customers to understand their unique challenges and deliver deep impact where it matters most. Previously, he held executive leadership roles at Kaplan Test Prep and Admissions, Reed Elsevier, Excerpta Medica, and Elsevier Health Sciences. Samios earned an MBA at Duke University and graduated from the University of Rochester with a B.S. and M.S. in Engineering.
Dr Bonis, who has served as Chief Medical Officer of Clinical Effectiveness since 2015, will now expand his scope to oversee division-wide industry partnerships, research and development initiatives, and deep collaborations with customers and partners. He was instrumental to the development of UpToDate into the leading clinical decision support tool used by doctors globally. Dr Bonis is a graduate of Harvard University and New York University School of Medicine. He was an assistant professor at Yale University School of Medicine and is currently an adjunct professor of medicine at Tufts University School of Medicine.
Stacey Caywood, Chief Executive Officer, Wolters Kluwer Health said, “Healthcare technology is rapidly changing the ways patients receive care, how clinicians make better decisions, and even how students learn to practice. I am excited to work with Greg and Peter in their new expanded roles to accelerate the innovation and customer success we deliver across our solutions at such an important time in the industry and global healthcare markets.”
Harish Ramachandran, Country Head for India at Wolters Kluwer Health said, “Healthcare across the globe is currently going through a paradigm shift. From approaching patient care reactively, now the situation demands a proactive approach, which includes, early-stage adoption of evidence-based medicine (EBM) for clinical effectiveness. The entire team of Wolters Kluwer India is thrilled to welcome both Greg and Peter in their new roles. Under their leadership, we look forward to a successful and committed journey that can drive innovation in the industry across geographies.”
The clinical effectiveness business is the largest business within Wolters Kluwer’s clinical solutions group that includes UpToDate clinical decision support solutions, Lexicomp® and Medi-Span® clinical drug information, and the Emmi® patient engagement solutions.
- Advertisement -